Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - NET CHANGE IN CASH
Net Change in Cash URGN - UroGen Pharma Ltd.
77.2 M
LAST VALUE
169.50%
2 YEAR CAGR
28.50%
5 YEAR CAGR
57.30%
10 YEAR CAGR